AstraZeneca

In News

Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice - Fierce Biotech

Fierce Biotech - Sep 18, 2026

Can AstraZeneca's Broad Pipeline Offset Recent Setbacks? - Yahoo Finance

Yahoo Finance - Sep 18, 2026

AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England - Reuters

Reuters - Sep 17, 2026

Europe's CHMP endorses slew of new medicines, including new offerings from Novo and AZ - Fierce Pharma

Fierce Pharma - Sep 18, 2026

England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal - STAT

STAT - Sep 17, 2026

A Life-Extending Breast Cancer Drug Finally Comes to England - Bloomberg.com

Bloomberg.com - Sep 16, 2026

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports - CNBC

CNBC - Aug 02, 2026

Pharmaceutical company bows to pressure, offers life-saving drug for free - ABC News & Headlines – Australian Broadcasting Corporation

ABC News & Headlines – Australian Broadcasting Corporation - Jul 29, 2026

AstraZeneca falls to third-largest UK company amid US merger talks - The Guardian

The Guardian - Aug 03, 2026

AstraZeneca investors raise concerns over mega-merger talks - Financial Times

Financial Times - Aug 03, 2026

Efzimfotase alfa granted Priority Review in the US as treatment for patients with hypophosphatasia aged 2 years and older - AstraZeneca US

AstraZeneca US - Sep 18, 2026

Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer - AstraZeneca

AstraZeneca - Sep 11, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment